Literature DB >> 23351017

Sweet's syndrome triggered by pneumococcal vaccination.

Ana Filipa Pedrosa1, Paulo Morais, Ana Nogueira, Joana Pardal, Filomena Azevedo.   

Abstract

Sweet's syndrome is the most frequent category among the neutrophilic dermatosis and is diagnosed by clearly defined criteria. Vaccines are included as potential triggers of this syndrome. Nevertheless, there are few reports unveiling such association. Herein, we describe the case of a patient who developed Sweet's syndrome after pneumococcal vaccination. To our knowledge, this is the second case of Sweet's syndrome triggered by pneumococcal vaccine reported, and the first one specifically with the 13-valent conjugate vaccine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23351017     DOI: 10.3109/15569527.2012.759960

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  6 in total

Review 1.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

2.  Injection Site Lichenoid Dermatitis Following Pneumococcal Vaccination: Report and Review of Cutaneous Conditions Occurring at Vaccination Sites.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2016-03-17

Review 3.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

4.  Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.

Authors:  Imran Majid; Samia Mearaj
Journal:  Dermatol Ther       Date:  2021-10-07       Impact factor: 3.858

5.  Sweet syndrome following Moderna COVID-19 vaccine: A case report.

Authors:  Frederic Pelchat; Cynthia Fournier; Emilie Perron; Martin Gilbert; Bernard Delisle
Journal:  SAGE Open Med Case Rep       Date:  2022-08-11

6.  Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.

Authors:  Anne-Sophie Darrigade; Hélène Théophile; Paola Sanchez-Pena; Brigitte Milpied; Marianne Colbert; Stéphane Pedeboscq; Thierry Pistone; Marie-Laure Jullié; Julien Seneschal
Journal:  Allergy       Date:  2021-07-03       Impact factor: 14.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.